Loading clinical trials...
Loading clinical trials...
Clinical Evaluation of the Safety and Effectiveness of Harvest Autologous Platelet Concentrate and Autologous Thrombin for Treatment of Lower Extremity Chronic Diabetic Ulcers
Autologous platelet concentrate will enhance the rate of healing of chronic diabetic wounds
The treatment of a diabetic wound with APC and thrombinhas the potential to accelerate the re-epithial process when compared with usual care. The study is a prospective, randomized, blinded, multicenter clinical evaluation.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Washington Regional Medical Center
Fayetteville, Alaska, United States
Lucerne Hospital
Orlando, Florida, United States
Bay Pines V.A. Medical Center
St. Petersburg, Florida, United States
New England Medical Center Hospital
Boston, Massachusetts, United States
Traveling Medical Services
Southfield, Michigan, United States
Blair Medical Associates
Altoona, Pennsylvania, United States
Roger Williams Hospital
Providence, Rhode Island, United States
Tennessee Christian Hospital
Madison, Tennessee, United States
St. Luke's Medical Ctr
Milwaukee, Wisconsin, United States
Start Date
June 1, 2004
Primary Completion Date
September 1, 2005
Completion Date
September 1, 2005
Last Updated
March 20, 2012
debridement, dressing, and APC
DEVICE
Lead Sponsor
Harvest Technologies
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07296484